--- title: "Intuitive Surgical: Setting the gold standard in robotic surgery" description: Intuitive Surgical shares have risen 184% in the past 3 years, but what's drawing the most attention to the company is innovation, pure and simple. image: https://insights.roboglobaletfs.com/hubfs/intuitive_surgical.jpg --- - [![](https://px.ads.linkedin.com/collect/?pid=2261676&conversionId=4842593&fmt=gif)Newsletter Signup](https://insights.roboglobaletfs.com/intuitive-surgical-gold-standard-robotic-surgery#newsletter-form) ### Newsletter Form ROBO Global uses this information to keep you up to date on the latest investment insights and technology trends. You may unsubscribe from these communications at any time. For more information, check out our [Privacy Policy](https://insights.roboglobaletfs.com/privacy). If you cannot see the form above, you may have an ad blocker preventing it from loading. Please disable the ad blocker and refresh the page. ### Contact Form If you cannot see the form above, you may have an ad blocker preventing it from loading. Please disable the ad blocker and refresh the page. BEGIN YOUR SEARCH... [![VettaFi_ROBO_WHITE-1](https://insights.roboglobaletfs.com/hs-fs/hubfs/VettaFi_ROBO_WHITE-1.png?width=4320&height=1440&name=VettaFi_ROBO_WHITE-1.png "VettaFi_ROBO_WHITE-1")](https://www.roboglobal.com/) - [RESEARCH & INSIGHTS](http://www.roboglobal.com/research-insights) - [MEET THE EXPERTS](http://www.roboglobal.com/about-us) - ROBO Global Indexes - [ROBO Index](https://www.roboglobal.com/robo-global-indices/robo-index/) - [THNQ Index](https://www.roboglobal.com/robo-global-indices/thnq-index/) - [HTEC Index](https://www.roboglobal.com/robo-global-indices/htec-index/) - [How to Invest](https://www.roboglobal.com/robo-etfs) - [ESG](http://www.roboglobal.com/esg-policy) # Investment Insights Authored by: Jeremie Capron Date: March 29, 2019 Category: [HTEC](https://insights.roboglobaletfs.com/tag/htec), [ROBO](https://insights.roboglobaletfs.com/tag/robo), [Healthcare](https://insights.roboglobaletfs.com/tag/healthcare), [Robotics](https://insights.roboglobaletfs.com/tag/robotics) Share this: - - - - [mailto:?subject=Intuitive%20Surgical:%20Setting%20the%20gold%20standard%20in%20robotic%20surgery&body=Intuitive%20Surgical:%20Setting%20the%20gold%20standard%20in%20robotic%20surgery%20https://insights.roboglobaletfs.com/intuitive-surgical-gold-standard-robotic-surgery](mailto:?subject=Intuitive%20Surgical:%20Setting%20the%20gold%20standard%20in%20robotic%20surgery&body=Intuitive%20Surgical:%20Setting%20the%20gold%20standard%20in%20robotic%20surgery%20https://insights.roboglobaletfs.com/intuitive-surgical-gold-standard-robotic-surgery) ##### Related Posts - [![Turnkey Tech Investing: August 2023 Market Brief](https://insights.roboglobaletfs.com/hubfs/ROBOBrief_Blog%20+%20Turnkey%20Tech-Sep-20-2023-04-28-59-7091-PM.png) Turnkey Tech Investing: August 2023 Market Brief](https://insights.roboglobaletfs.com/turnkey-tech-investing-august-2023) - [![Q2 In Review: Inside the ROBO, THNQ & HTEC Indexes](https://insights.roboglobaletfs.com/hubfs/Q1%202021-1.png) Q2 In Review: Inside the ROBO, THNQ & HTEC Indexes](https://insights.roboglobaletfs.com/q2-in-review-inside-the-robo-thnq-htec-indexes) - [![Automation Isn't Just For the Fortune 500](https://insights.roboglobaletfs.com/hubfs/SMEs%20Automation%20Webinar%20Deck%20(Tifin)%20(1).png) Automation Isn't Just For the Fortune 500](https://insights.roboglobaletfs.com/automation-isnt-just-for-the-fortune-500) - [![Q1 2023 In Review: ROBO, HTEC & THNQ](https://insights.roboglobaletfs.com/hubfs/Q1%202021.png) Q1 2023 In Review: ROBO, HTEC & THNQ](https://insights.roboglobaletfs.com/q1-2023-in-review-robo-htec-thnq) ## Intuitive Surgical: Setting the gold standard in robotic surgery ![Intuitive Surgical: Setting the gold standard in robotic surgery](https://insights.roboglobaletfs.com/hubfs/intuitive_surgical.jpg) ROBO Global index member [Intuitive Surgical](https://www.intuitive.com/) continues to drive the healthcare robotics revolution, and investors are taking note. Its shares have climbed 17% so far this year (as of March 25, 2019) and returned a total 184% in the past three years. That’s on the heels of a reported sales growth of 19% in 2018. But the current stock price isn’t what has been drawing the most attention to Intuitive Surgical in recent weeks. The main attraction has been innovation, pure and simple. Intuitive Surgical made a name for itself with its [da Vinci robotics surgery system](https://www.davincisurgery.com/da-vinci-surgery/da-vinci-surgical-system/), which was used to perform more than a million procedures in 2018. Providing a clear and highly magnified view inside the patient's body, this remarkable system of advanced instruments and 3D HD vision enables surgeons to perform surgeries using just a few small incisions rather than traditional methods of ‘open’ surgery. The company designs, manufactures, and markets the systems, as well as other da Vinci system-related instruments and surgical accessories such as surgeon's consoles, patient-side carts, 3-D vision systems, skills simulators, integrated table motions, and fluorescence imaging products. Da Vinci has transformed how surgeons perform a variety of surgical procedures, primarily urologic and gynecologic, but also increasingly general, cardiothoracic, and head and neck surgeries. The company launched 80 new products in its da Vinci ecosystem in the past three years alone, and as the technology continues to advance, the list of surgical applications da Vinci can support is likely to grow significantly. As is true in all areas of [healthcare](http://roboglobal.com/tag/healthcare/), a global aging population is leading to a substantial increase in the number of surgical procedures performed, a growing part of which can be assisted by robotics and [AI](http://roboglobal.com/tag/ai/). Going forward, treating lung cancer—the world’s leading cause of cancer deaths—is at the top of the list. Intuitive Surgical’s new Ion™ surgical system is set to transform how surgeons treat this deadly disease. The company [recently announced FDA clearance for Ion](https://isrg.intuitive.com/news-releases/news-release-details/u-s-fda-grants-clearance-ion-intuitive), which uses flexible robotic catheters that are enabled by AI and computer vision to obtain lung biopsies in a minimally invasive procedure. Ion makes it possible to navigate around tiny curves within the body, and its tiny, ultra-thin (2mm) catheter can even be used to gather biopsies using miniature forceps or to collect cell samples using a cytology brush. Gary Guthart, Intuitive Surgical’s CEO, has indicated that that product is expected to do particularly well in markets where cases of lung cancer and lung diseases are on the rise—including [China](http://roboglobal.com/tag/china/).[\[1\]](https://insights.roboglobaletfs.com/intuitive-surgical-gold-standard-robotic-surgery#_ftn1) The company plans to begin shipping the Ion system as early as 2Q19. It’s no surprise that Intuitive Surgical’s success, both past and present, has created a stir among the competition. Just last month, Johnson & Johnson made headlines for its [acquisition of Auris Health](https://www.jnj.com/johnson-johnson-announces-agreement-to-acquire-auris-health-inc) for $3.4B in cash. The purchase adds Monarch, Auris’s FDA-approved robotics system for diagnosing and treating lung cancer, to its robotics and AI initiative centered on [Verb Surgical](https://www.verbsurgical.com/), a joint venture formed in 2015 with [Verily](https://verily.com/) (formerly Google Life Sciences). And J&J isn’t the only healthcare player seeking to boost its presence in the fast-growing field of robotic surgery. Last year, [Medtronic](https://www.medtronic.com/us-en/index.html) completed the $1.6B acquisition of former ROBO Index member Mazor Robotics, the pioneer and leader in robotics solutions for spine surgery. In late 2013, [Stryker acquired Mako](https://www.stryker.com/us/en/portfolios/orthopaedics/joint-replacement/mako-robotic-arm-assisted-surgery.html), which specializes in orthopedic robotics surgery, for a similar amount. In 2016, [Zimmer Biomet](https://www.meddeviceonline.com/doc/zimmer-biomet-acquires-medtech-sa-joins-surgical-robotics-fray-0001) acquired French surgical robotics maker MedTech SA. The increase in competition will no doubt bring more good news for patients, but it’s unlikely to dampen the trajectory of Intuitive Surgical. As the bona fide market gorilla, the company has already garnered the lion’s share of the current market, and its track record of delivering consistent quality has created a high level of customer loyalty. We view Intuitive Surgical’s competitive position as very strong. First, its track record of innovation is remarkable. As emerging competitors strive to prove their ability to deliver their own high-quality, high-value solutions, the company will likely barrel ahead with new innovations and, as a result, continue to build on its already impressive market dominance and strengthen its lead. Second, the company’s offering is increasingly integrated, with multiple interconnected systems (X, Xi, SP, and now Ion). Third, its training, education and support services are enabled by more than 2,000 da Vinci simulators, as well as fully developed training protocols. Lastly, Intuitive Surgical has a significant data advantage across a wide array of specialties. We anticipate continued high-teens growth in 2019 and beyond. The company reported cash, cash equivalents, and investments of $4.8B at the end of 2018, giving it plenty of resources to boost its already impressive R&D expenditures and to make strategic acquisitions. The market for surgical robotics is already large. With TAM expected to expand dramatically for spinal, orthopedic, and bariatric surgeries, it appears that Intuitive Surgical has plenty of room to grow. *By [Jeremie Capron](http://roboglobal.com/our_team/jeremie-capron/), Director of Research, ROBO Global* --- [\[1\]](https://insights.roboglobaletfs.com/intuitive-surgical-gold-standard-robotic-surgery#_ftnref) “Intuitive Surgical CEO: Helping surgeons avoid harming healthy tissue,” CNBC, March 5, 2019   [Back to All Entries](https://insights.roboglobaletfs.com) VettaFi, a data, analytics, and thought leadership company, is transforming financial services from an industry to a community—one relationship at a time. In addition to providing interactive online tools and research, VettaFi offers asset managers an array of indexing and digital distribution solutions to innovate and scale their businesses. With billions in assets benchmarked to its indices– and more than 200 customers globally – asset managers look to VettaFi for benchmarks and best-in-class index solutions. VetttaFi owns and administers the ROBO Global Index Series. ## Navigation - [Home](http://www.roboglobal.com) - [ROBO Research](http://www.roboglobal.com/whitepapers) - [Investment Insights](https://insights.roboglobaletfs.com) - [ROBO Index](http://www.roboglobal.com/robo-global-indices/robo-index) - [THNQ Index](http://www.roboglobal.com/robo-global-indices/thnq-index) - [HTEC Index](http://www.roboglobal.com/robo-global-indices/htec-index) ### Newsletter Signup My rich text default content © 2026 ROBO Global Index, LLC. All Rights Reserved ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Jeremie Capron", "url" : "https://insights.roboglobaletfs.com/author/jeremie-capron" }, "dateModified" : "2021-04-27T19:07:23.310Z", "datePublished" : "2019-03-29T18:36:22.000Z", "headline" : "Intuitive Surgical: Setting the gold standard in robotic surgery", "image" : [ "https://insights.roboglobaletfs.com/hubfs/intuitive_surgical.jpg" ], "mainEntityOfPage" : { "@id" : "https://insights.roboglobaletfs.com/intuitive-surgical-gold-standard-robotic-surgery", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://insights.roboglobaletfs.com/hubfs/Imported%20images/ROBO_LOGO_WITHTAG_STACKED_BLUE.png" }, "name" : "ROBO Global & Range ETFs" } } ```